Clinical Trial Update: Insulin Resistance in Nonalcoholic Fatty Liver Disease: A Case Control Study

View source ↗

Summary

The Duke University–sponsored case-control study evaluating insulin resistance in nonalcoholic fatty liver disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Nonalcoholic Fatty Liver Disease

Snippet

Sponsor: Duke University | Conditions: Insulin Resistance, Nonalcoholic Fatty Liver Disease | Status: TERMINATED